Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/6775
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Haynes, D. | - |
dc.contributor.author | Crotti, T. | - |
dc.contributor.author | Potter, A. | - |
dc.contributor.author | Loric, M. | - |
dc.contributor.author | Atkins, G. | - |
dc.contributor.author | Howie, D. | - |
dc.contributor.author | Findlay, D. | - |
dc.date.issued | 2001 | - |
dc.identifier.citation | Journal of Bone and Joint Surgery: British Volume, 2001; 83B(6):902-911 | - |
dc.identifier.issn | 0301-620X | - |
dc.identifier.issn | 2044-5377 | - |
dc.identifier.uri | http://hdl.handle.net/2440/6775 | - |
dc.description.abstract | Extensive osteolysis adjacent to implants is often associated with wear particles of prosthetic material. We have investigated if RANKL, also known as osteoprotegerin ligand, osteoclast differentiation factor or TRANCE, and its natural inhibitor, osteoprotegerin (OPG), may be important in controlling this bone loss. Cells isolated from periprosthetic tissues containing wear particles expressed mRNA encoding for the pro-osteoclastogenic molecules, RANKL, its receptor RANK, monocyte colony-stimulating factor (M-CSF), interleukin (IL)-1ß, tumour necrosis factor (TNF), IL-6, and soluble IL-6 receptor, as well as OPG. Osteoclasts formed from cells isolated from periprosthetic tissues in the presence and absence of human osteoblastic cells. When osteoclasts formed in the absence of osteoblastic cells, markedly higher levels of RANKL mRNA relative to OPG mRNA were expressed. Particles of prosthetic materials also stimulated human monocytes to express osteoclastogenic molecules in vitro. Our results suggest that ingestion of prosthetic wear particles by macrophages results in expression of osteoclast-differentiating molecules and the stimulation of macrophage differentiation into osteoclasts. | - |
dc.description.statementofresponsibility | D. R. Haynes, T. N. Crotti, A. E. Potter, M. Loric, G. J. Atkins, D. W. Howie, and D. M. Findlay | - |
dc.language.iso | en | - |
dc.publisher | British Editorial Soc Bone Joint Surgery | - |
dc.rights | Copyright © 2001 by British Editorial Society of Bone and Joint Surgery | - |
dc.source.uri | http://www.jbjs.org.uk/cgi/content/abstract/83-B/6/902 | - |
dc.subject | Cells, Cultured | - |
dc.subject | Macrophages | - |
dc.subject | Osteoclasts | - |
dc.subject | Osteolysis | - |
dc.subject | Glycoproteins | - |
dc.subject | Tumor Necrosis Factor-alpha | - |
dc.subject | Carrier Proteins | - |
dc.subject | Macrophage Colony-Stimulating Factor | - |
dc.subject | Membrane Glycoproteins | - |
dc.subject | Receptors, Tumor Necrosis Factor | - |
dc.subject | Receptors, Cytoplasmic and Nuclear | - |
dc.subject | RNA, Messenger | - |
dc.subject | Interleukin-6 | - |
dc.subject | Cytokines | - |
dc.subject | Reverse Transcriptase Polymerase Chain Reaction | - |
dc.subject | RANK Ligand | - |
dc.subject | Receptor Activator of Nuclear Factor-kappa B | - |
dc.subject | Osteoprotegerin | - |
dc.title | The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1302/0301-620X.83B6.10905 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Crotti, T. [0000-0002-5422-3758] | - |
dc.identifier.orcid | Atkins, G. [0000-0002-3123-9861] | - |
dc.identifier.orcid | Howie, D. [0000-0003-1702-3279] | - |
Appears in Collections: | Aurora harvest 5 Orthopaedics and Trauma publications Pathology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.